The wetlands at the 202 Munitions Works site in Taipei City’s Nangang District (南港) are known as “the lungs of Taipei.” Plans to build a biotechnology park on the site have caused a standoff between environmentalists on one hand and an alliance between the government and developers on the other.
Setting aside for the moment the rights and wrongs of the matter, the motivation for such a development plan is an important question deserving of serious consideration. The question is — can building a biotech park on the 202 Munitions Works site save the day for Taiwan’s biotech sector?
Taiwan has been promoting biotechnology since 1983, making it quite an early starter in the field, but 27 years later the results have not measured up to expectations. It was hoped that biotechnology would, like the electronics industry before it, work a miracle for Taiwan’s economy. The reality today, however, is that Taiwan’s biotech sector lags behind not only our neighbors Japan, South Korea, Singapore and China, but also small countries like Cuba and Israel, while Southeast Asia’s Malaysia and Thailand could catch up with Taiwan before long.
There are many reasons for this, but the ridiculous thing is that while our biotech industry has failed to get off the ground, Taiwan has achieved a different kind of “miracle” — the world’s highest concentration of biotech industrial parks.
At present, eight such parks in Taiwan have been approved and started operations and more are being added. The eight parks in operation are: the Biotechnology Plaza in Taipei’s Nankang Software Park; Hsinchu Biomedical Science Park; Pingtung Agricultural Biotechnology Park, set up under the auspices of the Council of Agriculture; Changhua County National Flower Park; Taiwan Orchid Plantation in Tainan County; Chiayi Herbs Biotechnology Park; Yilan Ocean Biotechnology Park; and Southern Taiwan Science Park in Kaohsiung County.
To this number could be added Jhunan Base in Hsinchu County, Hualien Deep Sea Water Park and the Tainan and Lujhu science parks, which are attached to the Southern Taiwan Science Park, so there are actually more than 10 such parks already in operation. Taiwan has such a high concentration of biotech parks that soon there will be one in every county. Several of these parks focus on orchids and other flowers and on culinary and medicinal herbs. To build so many agriculture-oriented biotech parks with overlapping roles is a big waste of resources.
Do domestic and overseas biotech companies require such extensive facilities? The company occupancy rate of most of these biotech parks is 30 percent or less. Why is it that after requisitioning so much land and spending such great human and physical resources, so few companies want to move into the parks?
At this stage, while Taiwan’s biotech sector has yet to take off, what biotech firms need most is not land or factories, but funding to support their operations, research and development. They need talented people who can do innovative research and work on overseas marketing, commercialization and mass production. What they need even more is a strong educational foundation and infrastructure on which to build the industry, as well as complementary measures such as appropriate laws and regulations.
What they do not need at this stage is empty hardware in the form of industrial parks scattered here and there, whose real purpose is to be flaunted as political achievements when politicians are campaigning for re-election.
Taiwan’s biotech medicine industrial base is weaker than that of countries in Europe and America, so it has much room for future development. Based on the experience of advanced biotech producers in Europe, America and Japan, biotechnology parks should be based around existing technologies and then combined with surrounding resources, so as to generate collective energy and a cluster effect in which one plus one adds up to more than two. That is the most helpful model for building a biotech sector.
In Taiwan, in contrast, cities and counties are falling over one another to get the go-ahead for biotech parks. Generally, they think biotechnology is where the money is. The central government, seeing biotech as a key area for scientific development, is willing to give it a big budget — and that can be a welcome supplement for scant financial resources at the local level. Besides, it gives local politicians a chance to show off their achievements in office. Local governments give little consideration to fair allocation of the nation’s overall resources, or to the matter of whether they are capable of building clusters of biotech industry with local characteristics.
Government decision-makers, lacking a long-term perspective, think that setting up biotech parks can demonstrate the government’s determination to promote the biotech industry and get it off the ground. However, this has turned out to be an illusion and this is one aspect of Taiwan’s erroneous biotech industrial development policies over the past quarter-century.
Building yet another biotech park on the 202 Munitions Works site would be of no benefit to Taiwan’s biotech sector under today’s conditions. We don’t need so many biotech parks and we don’t need any more government interference in the sector’s development. Only with a change in policy direction can Taiwan have a future in which life science students don’t face unemployment after they graduate.
Chiang Hoang-yung is a doctor of biochemistry and president of the Taiwan Bio-Foundation.
TRANSLATED BY JULIAN CLEGG
Concerns that the US might abandon Taiwan are often overstated. While US President Donald Trump’s handling of Ukraine raised unease in Taiwan, it is crucial to recognize that Taiwan is not Ukraine. Under Trump, the US views Ukraine largely as a European problem, whereas the Indo-Pacific region remains its primary geopolitical focus. Taipei holds immense strategic value for Washington and is unlikely to be treated as a bargaining chip in US-China relations. Trump’s vision of “making America great again” would be directly undermined by any move to abandon Taiwan. Despite the rhetoric of “America First,” the Trump administration understands the necessity of
US President Donald Trump’s challenge to domestic American economic-political priorities, and abroad to the global balance of power, are not a threat to the security of Taiwan. Trump’s success can go far to contain the real threat — the Chinese Communist Party’s (CCP) surge to hegemony — while offering expanded defensive opportunities for Taiwan. In a stunning affirmation of the CCP policy of “forceful reunification,” an obscene euphemism for the invasion of Taiwan and the destruction of its democracy, on March 13, 2024, the People’s Liberation Army’s (PLA) used Chinese social media platforms to show the first-time linkage of three new
If you had a vision of the future where China did not dominate the global car industry, you can kiss those dreams goodbye. That is because US President Donald Trump’s promised 25 percent tariff on auto imports takes an ax to the only bits of the emerging electric vehicle (EV) supply chain that are not already dominated by Beijing. The biggest losers when the levies take effect this week would be Japan and South Korea. They account for one-third of the cars imported into the US, and as much as two-thirds of those imported from outside North America. (Mexico and Canada, while
The military is conducting its annual Han Kuang exercises in phases. The minister of national defense recently said that this year’s scenarios would simulate defending the nation against possible actions the Chinese People’s Liberation Army (PLA) might take in an invasion of Taiwan, making the threat of a speculated Chinese invasion in 2027 a heated agenda item again. That year, also referred to as the “Davidson window,” is named after then-US Indo-Pacific Command Admiral Philip Davidson, who in 2021 warned that Chinese President Xi Jinping (習近平) had instructed the PLA to be ready to invade Taiwan by 2027. Xi in 2017
RSS